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Obesity is a chronic relapsing condition affecting a rapidly increasing number of people worldwide. 
The United Nations has stated that universal health coverage is an essential element of the globally-
agreed sustainable development goals. This paper provides a preliminary report of a survey of 
relevant health professionals and other interest groups on the readiness of health systems to provide 
obesity treatment services. Interviews and questionnaires were completed by 274 respondents from 
a total of 68 low, middle and high income countries. Respondents in the majority of countries stated 
that there were professional guidelines for obesity treatment, but that there was a lack of adequate 
services, especially in lower income countries, and in rural areas of most countries. Lack of 
treatment was attributed to a broad range of issues including: no clear care pathways from primary 
care to secondary services; absent or limited secondary services in some regions; lack of trained 
multi-disciplinary support professionals; potentially high costs to patients; long waiting times for 
surgery; and stigma experienced by patients within the health care services. Defining obesity as a 
disease may help to overcome stigma and may also help to secure better funding streams for 
treatment services. However, the survey found that few countries were ready to accept this 
definition. Furthermore, until countries fully adopt and implement obesity prevention policies the 









Worldwide, the prevalence of obesity in the adult population rose during the last decade and 
without significant interventions will increase further in the coming decade. In 2011 the United 
Nations General Assembly agreed a Political Declaration on the Prevention and Control of Non-
Communicable Diseases (NCDs), that called on member states to achieve by 2025 a 25% reduction 
in mortality for NCDs and no increase in the prevalence of adult obesity or diabetes above 2010 
levels.1 In 2019, the General Assembly adopted a Political Declaration promoting universal health 
coverage for achieving the sustainable development goals.2 The World Health Organization (WHO) 
estimates that an additional USD200 billion a year invested in scaling up primary health care across 
low and middle income countries would potentially save 60 million lives, increase average life 
expectancy by 3.7 years by 2030, and contribute significantly to socio-economic development.3 
This investment would represent about 3% increase on the USD7.5 trillion already spent on health 
globally each year. 
 
By 2025, global obesity prevalence is predicted to reach 18% in men and surpass 21% in women.4 
Of these, an estimated 257m adults worldwide (6% of men and 9% of women) are forecast to be 
living with severe obesity (defined here as a body mass index > 34.9k/m2 or more) in 2025, 
showing a rapid increase from an estimated 173m in 2014.5 These projections indicate a significant 
need for treatment provided by national health services. Left untreated, the consequences of obesity 
are likely to escalate, as the duration of obesity increases the likelihood of more disabling diseases 
requiring greater intensity of interventions.6, 7 
 
We report here the results of a series of semi-structured interviews and questionnaires with 
interested parties in a preliminary sample of 68 countries. The data collection was designed to 





A mixed methods approach was taken to data collection, using face-to-face interviews, online 
interviews and online questionnaires in seven languages (English, Arabic, French, German, Italian, 
Portuguese, and Spanish). Information was collected, interviews were conducted and questionnaires 
completed between May 2018 and August 2019.  
 
Respondents for interviews and online questionnaires were recruited through World Obesity 
Federation member organisations, social media (Twitter, LinkedIn), other professional society 
newsletters and authorship of relevant published papers. All coherent responses were considered 
valid for inclusion in the analyses, including partially completed responses, and although 
respondents were asked to state their occupation, no attempt was made to stratify the analyses by 
respondents’ training or experience  
 
For the purposes of analysis, we have summarised the key issues relating to obesity management 
according to country income level, country health care expenditure (higher and lower tertiles) and 
anticipated adult obesity prevalence (higher and lower tertiles). For country income levels we 
combined data for low income and lower-middle income countries (here referred to as LLMI), to 
contrast with data for upper-middle income (UMI) and high income (HI) countries, according to 
World Bank income categories8 (see Table 1). Countries were also categorised according to their 
current national health care expenditure as a percentage of gross domestic product, provided by the 
World Bank9 with additional information from Hong Kong and Taiwanese government websites. 
Countries were divided into tertiles of low, middle and high health care expenditure (see 
Supplementary Table 1). Finally, countries were categorised into tertiles of lower, medium and 
higher predicted prevalence levels for severe obesity (BMI > 34.9 kg/m2) in 20255, (see 
Supplementary material). 
 
The questions for survey and interview were developed and shared with the advisory committee 
then amended accordingly. A short preliminary survey was piloted, responses reviewed, and the 
protocol further extended and adapted. Variations in the survey were permitted in different regions 
and over time. Data were requested from respondents in several formats, included ratings, multiple 
choice answers and open-ended statements. Respondents were informed that their responses would 
be used anonymously in summary tables only. The interview and survey protocols are shown in 
Supplemental material.  
 
Interview and questionnaire responses were analysed by two researchers separately and compared. 
Differing interpretations were discussed with a third researcher to reach agreement. Some 
respondents were re-contacted for clarification of their responses. An interview conducted jointly 
with two or more respondents was scored as a single response. When multiple responses were 
available for a given country, a consensus ‘country description’ was derived by agreement among 




Ratings were scaled from ‘0’ (low rating) to ‘10’ (high rating). When multiple respondents’ ratings 
were available for a single country, a simple mean score was calculated. Groups of countries were 
compared non-parametrically using chi-squared for the sum of mean ratings: for example, for a 
given rating question, if the mean scores for three lower income countries were 3/10, 4/10, and 
5/10, while for four higher income countries the scores were 4/10, 6/10, 7/10, and 8/10, then a chi-
squared test compared the total score of 12/30 for lower income countries with the total of 25/40 for 
the higher income countries (in this case giving a chi-squared value of 3.48, p=0.06).  
 
In the case where respondents were asked to identify what they considered to be the top five 
barriers to treatment in rank order, the responses were categorised by two researchers and reduced 
in two rounds to 30 specific barriers. These were then combined into country groups after adjusting 
for the number of respondents in each country, and rank ordered in frequency of mention, 
 
Questions comparing services for rural populations were not used for countries where less than 5% 




Survey data were collected for 68 countries. Information for the United Kingdom was analysed 
separately for England and Scotland because the two regions have separate health care systems. 
Countries included 15 classified as low- and lower-middle income (LLMI), 23 as upper-middle 
income (UMI), and 30 as high income (HI). Semi-structured interviews and questionnaires were 
conducted with a total of 274 individuals, giving an average of just under four respondents per 
country, but with wide variation, ranging from a single respondent from each of 15 countries 
through to 20 respondents from Mexico alone (shown in Table 1). Professionals providing 
responses included many health service multi-disciplinary team members, as well as members of 
health advocacy organisations, patients and others (most of whom were researchers or student 
health care professionals) (Table 2). 
 
3.1 Available guidelines 
Respondents in forty-two of the countries stated that professional guidelines for weight 
management or obesity treatment were available for adults and/or children (Table 3). There was no 
difference in the proportion of countries with available guidelines across the income levels (X2 = 
3.99, p=0.14 – see Table 3). There was also no difference in the availability of guidelines between 
countries with high and low health care expenditure or between countries with high and low obesity 
prevalence (Table 3). 
 
3.2 Rating of health system 
Respondents were asked to rate the ability of the national health systems to care for people with 
obesity (Table 4). Based on ranking from 0 (very poor) to 10 (excellent), countries were typically 
scored at 4.2, or somewhat below the mid-point. Health systems in lower income countries tended 
to be given poorer scores than upper-middle and high income countries. Interestingly, countries 
with a higher level of health care expenditure scored significantly less well than those with lower 
health care expenditure (X2 = 6.36, P=0.01 – see Table 4). There was no difference in scores 
between countries with higher and lower obesity prevalence rates (Table 4).  
 
3.3 Access to care services 
Four options for access to treatment were examined: via family physician referral, directly to 
specialist services, as a consequence of admission for complications, or via a screening exercise. 
Respondents in just over half of all countries (36 of 68) stated that access to care services was 
available via family physicians, while nearly half (30 of 68) stated that access was available 
following complications arising from obesity (Table 3). These are not mutually exclusive. In almost 
15% of countries (10 of 68) access could be obtained through specialist services, and in 10% (7 of 
68) access was reportedly available through screening programmes.  
 
Access to care through family physicians differed according to country category: it was more 
frequently reported in high income countries compared with low income countries (X2 = 7.90, 
p<0.02) and in countries with higher obesity prevalence compared with countries with lower 
prevalence (X2 = 6.42, p<0.02– see Table 3). There was no difference between countries according 
to the level of their health care expenditure.  
 
There were no differences between country categories for the proportions of respondents reporting 
access to obesity treatment following admission for complications (Table 3). Numbers were too 
small for statistical analysis of other routes of access. 
 
3.4 Urban versus rural services 
Respondents rated treatment availability in urban and rural areas. Ratings were generally lower in 
rural areas (average 2.3 points) than in urban areas (average 4.5 points) across all countries (X2 = 
67.17, p<0.001 – see Table 4). This finding was found consistently in lower and higher income, 
lower and higher health care expenditure, and lower and higher obesity prevalence categories 
(Table 4).  
 
3.5 Treatment not completed 
Respondents were asked an open-ended question about their experience of the reasons why patients 
may leave treatment or cease to use the provided services. The most common response was ‘a 
failure to refer’, followed by ‘a lack of care pathways’ (Table 3). Additional reasons given by 
respondents in at least ten countries were ‘failure of treatment’, ‘lack of patient motivation or 
compliance’, ‘cost of treatment’ and ‘otherwise lost to follow-up’.  
 
‘Failure to refer’ and ‘lack of care pathway’ were cited most often as the reason for uncompleted 
treatment in all categories of country: lower and higher income, low and high health care 
expenditure, and low and high obesity prevalence levels.  
 
3.6 Multi-disciplinary training  
Training in the various skills that make up a multi-disciplinary team capable of providing a range of 
treatment and weight management services appeared very inconsistent. Of 68 countries, 29 were 
reportedly provided adequate training of nutritionists and dietitians, but only four countries 
provided adequate training of paediatric obesity specialists. Rank ordering of the adequacy of 
training for different specialities was similar across the three categories of country income (Kendall 
concordance w=0.72, p<0.05), and country obesity prevalence (Spearman r= 0.66, p<0.05) but not 
for health care expenditure (Spearman r=0.35, NS) (Table 3). 
 
3.7 Funding of treatment 
Regarding funding for obesity treatment, respondents gave multiple conflicting answers in some 
countries and answers that were unclear or could not be scored in others. Part of the difficulty may 
have been the ambiguity of definitions: in many countries the answer given may be ‘out of pocket’ 
although in some cases these costs may have been later reimbursed by insurance schemes. In some 
countries, multiple funding sources operate simultaneously for different population groups. In 
Mexico, for example, funding arrangements for public sector employees differ from those for 
private sector employees, and differ again for low income families. Within any funding source there 
may be variations in what would be funded and what the patient would have to pay.  
 
3.8 Barriers to treatment 
Respondents were asked to provide their ‘top five’ barriers to the provision of adequate treatment 
services. Responses were collated for each country and the tally for each of 30 identifiable 
responses calculated, after weighting to adjust for the number of respondents answering the 
question, to ensure that every country’s contribution to the total was equal. The resulting scores are 
shown in Table 5. Most commonly stated barriers were ‘lack of political will or interest’, ‘lack of 
trained professionals, and lack of training available’, high costs of out-of-pocket payments’, ‘poor 
health literacy and poor behaviour’, ‘lack of recognition of obesity as a disease’, and the prevailing 
‘obesogenic environment’.  
 
Rank scoring of the barriers to treatment country categories showed strong correlational 
concordance between countries of different income levels, with Kendall’s coefficient of 
concordance w=0.73 (p<0.001 – see Table 5). Despite the high concordance, inspection of Table 5 
indicates several anomalies in the ordering of scores between the income categories. For LLMI 
countries, stigma and belief in individual responsibility ranked very low (30th) compared with HI 
countries (rank 2nd). Surprisingly, poor availability of pharmaceutical treatments ranked low in 
LLMI countries (22nd) possibly due to a lack of knowledge of the availability of such treatment, but 
relatively higher in UMI and HI countries (9th and 11th respectively). Similarly, lack of multi-
disciplinary teams ranked very low in LLMI countries (29th) but more highly in UMI (14th) and HI 
(19th) countries.  
 
3.9 Moves to accept obesity as a disease 
Respondents were asked to assess their countries’ recognition of obesity as a disease, both at the 
governmental level and among health care providers. Ratings averaged 5.0 (on a scale from 0 = ‘not 
at all’ to 10 = ‘yes completely’) for both government and for service providers taking all countries 
together. There was some ambiguity in how respondents interpreted the phrase ‘health care 
provider’. Some assumed this meant the clinical services or health professional bodies and some 
assumed it meant the funding agencies, such as health insurers. Any future survey should seek to 
disambiguate this phrase. 
 
Respondents in low and lower-middle income countries gave a lower rating of their governments’ 
move to defining obesity a disease compared with respondents in upper-middle and high-income 
countries (X2 = 4.94, p=0.08). Similarly, lower income countries gave lower ratings of their health 
care providers accepting obesity as a disease, compared with higher income countries (X2=5.66, 
p=0.06). Respondents in countries with lower health care expenditure gave a lower score for their 
governments’ moves to accept obesity as a disease than countries with higher health care 
expenditure (X2 = 3.09, p=0.08). Otherwise, ratings for governments and health care providers did 




The purpose of this study was to provide preliminary insights into the provision of services for the 
treatment of people with obesity. Over 270 partial or complete survey responses were collected 
from a total of 68 countries, including 15 low and lower-middle income countries, 23 upper-middle 
income and 30 high income countries. Respondents included a wide range of health care 
professionals and a small number of additional respondents from advocacy organisations, patients 
and others (largely research institutions and student health professionals). 
 
The responses indicated that a majority of countries had professional guidelines for obesity 
treatment. The question was open-ended and included guidelines for the criteria for acceptance for 
bariatric surgery, general definitions for referral to secondary services by family physicians, or 
definitions to be used for screening in paediatric services. Government-approved guidelines 
appeared to be available for a few countries, while guidelines developed by health care 
professionals’ organisations were available in more countries.  
 
Access to obesity treatment services was mainly though family physicians or as a result of 
treatment of obesity-associated complications. Higher income countries and countries with a higher 
prevalence of obesity appeared to have greater access to services through family physicians. For all 
categories of country, access to services was poorer in rural than urban areas. 
 
Failure of treatment was explored with an open-ended question. Respondents identified ‘failure to 
refer’ and ‘lack of care pathway’ most frequently, across all country categories, indicating a serious 
shortfall in service provision available to most eligible patients. Treatment costs were also 
suggested as a disincentive for patients to adhere to treatment, along with treatment failure, 
suggesting that the forms of treatment may not be adequate, multi-disciplinary teams’ skills may be 
insufficient or unavailable, or patient adherence may be overwhelmed by contextual factors in their 
family or social environments.  
 
Training of professionals across the range of specialties needed for a multi-disciplinary team was 
considered poor in many countries and for many of the areas of expertise needed. Nutrition and 
dietetics professionals appeared to be most frequently trained staff groups, while training in 
paediatric obesity care was least. Lower income countries suffered from the lack of specialist 
training most acutely. 
  
The costs to patients of obesity treatment were unclear. While out-of-pocket costs were widely 
acknowledged, the extent to which these might be refunded by insurance schemes was uncertain. 
Furthermore, countries appear to vary considerably in the forms of service available, what is funded 
by the state and what is available for lower income families. Further research is needed to obtain 
greater clarity on a country-by-country basis. 
 
There was considerable agreement among respondents on the main barriers to successful treatment 
faced by people living with obesity. Most commonly cited in all country categories were a ‘lack of 
political will or interest’, a lack of trained professionals, high out-of-pocket costs and lack of 
investment in services. These responses emphasise the potential role of government and health care 
funding bodies to ensure better provision of services.  
 
Also commonly stated as barriers to successful treatment were ‘poor health literacy or behaviour’ 
and also stigma and belief in individual responsibility. These responses describe an underlying 
attitude to obesity treatment held by health care professionals that emphasises the need for 
behaviour change and personal commitment, and the corollary assumption that treatment failure is a 
lack of commitment. Patients may react to these assumptions negatively and cease to attend 
treatment sessions in turn confirming the professionals’ biases.11, 12  
 
For health professionals and some patients, classifying obesity as a disease may help overcome the 
assumption that obesity is an individual responsibility and that treatment failure reflects the lack of 
a personal commitment. Moves to have obesity formally accepted as a disease by governments, 
health professionals and health insurers were rated by respondents at an average of 5 points, 
midway on a scale from 0 (no moves) to 10 (fully accepted), but countries differed in ratings 
according to their level of economic development, with significantly lower ratings from 
respondents in low and lower-middle income countries.  
 
A further commonly stated barrier to successful treatment was the ‘obesogenic environment’ which 
was seen as hampering long-term weight maintenance. It is increasingly recognised that successful 
weight maintenance during or after treatment depends on individuals being able to maintain health-
promoting diets and adequate physical activity, which is in turn influenced by the patient’s social, 
financial, physical, and environmental circumstances. While additional questions were asked about 
prevention of obesity in national policies and practices, these are not reported here. Having such 
policies accepted at the national level may help improve the narrative from one of individual 
responsibility to one which recognises the social, environmental and commercial drivers of obesity 
and, to the extent that prevention policies can serve to reduce the obesogenicity of the environment, 
treatment for obesity and maintenance after weight loss may be more successful.  
 
4.1 Country categories 
The 68 countries were divided into categories according to World Bank income levels (gross 
national income per capita), health care expenditure as a proportion of GDP and projected 
prevalence levels of severe obesity among adults. Results were remarkably consistent across these 
categorisations although a few differences were noticeable: respondents in lower income (LLMI) 
countries tended to report poorer ability of their health services to care for people with obesity, and 
access to treatment for obesity was obtained more often as a part of treatment for complications of 
obesity rather than through family physician referral for obesity in itself. Lack of trained 
professionals or lack of training facilities were more often cited in LLMI countries. Moves to define 
obesity a disease were scored at a lower level in LLMI countries compared with upper-middle and 
high income countries.  
 
In countries differentiated by level of health care expenditure as a percentage of GDP, respondents 
showed similar responses to most questions. However, and perhaps contrary to expectations, 
respondents from countries with a higher level of health care expenditure gave a lower rating for 
their ability to provide care for people with obesity, and gave a lower score for their efforts to 
define obesity as a disease. It is possible that in better-funded health services the health care 
professionals responding to this survey had higher expectations and a greater sense of 
dissatisfaction with the services for people with obesity. 
 
When countries were compared based on their level of severe adult obesity, responses were similar 
between higher and lower prevalence countries. Countries with a higher prevalence of severe 
obesity were more likely to offer access to services through family physicians compared to 
countries with lower prevalence levels.  
 
4.2 Limitations  
The preliminary insights provided by this survey are subject to a number of methodological 
concerns which we would attempt to rectify if this survey is to be extended. Firstly, we did not 
differentiate questions concerning secondary treatment services into sub-categories, such as 
pharmaceutical treatment, bariatric surgery, or various behaviour change approaches, nor 
investigate the provision of services for pediatric populations. 
 
A second concern is that, while we successfully captured a wide range of responses across relevant 
professionals and interest groups, the result is a pool of information that has a limited capacity for 
categorical analyses. Respondents were self-selected, and there were too few members of any 
specialty, apart from nutritionists/dietitians, to allow comparison between respondent categories. 
The uneven response rate across the specialties may not have provided a representative view 
concerning the adequacy of services, training and referral pathways.  
 
A third concern is the interpretation of results, especially where open-ended or potentially 
ambiguous questions were posed, and when respondents may not have been familiar with the 
language being used. This problem was especially noticeable in questions about funding of 
services, where there was some ambiguity on what was meant by ‘out-of-pocket’ and difficulty in 
generalizing when different population groups were funded differently. 
 
Throughout this research, the results collected and reported here are based on individuals’ 
knowledge and views about the services available, rather than a direct assessment of the services 
themselves.  
 
Lastly, it needs to be noted that attitudes towards obesity in lower and middle income countries will 
be complicated by the major nutritional transitions experienced in recent decades. The persistence 
of undernutrition and stunting, and the occurrence of both obesity and stunting in the same 





United Nations member states have committed to advance towards universal health coverage by 
investing in key areas: to ensure no one suffers financial hardship because they have had to pay for 
healthcare out of their own pockets; implementing high-impact health interventions to combat 
disease; protecting women’s and children’s health; strengthening the health workforce and 
infrastructure; and reinforcing governance capacity13. This paper provides a preliminary report of 
the state of services for the treatment of obesity in a sample of countries, based on interviews and 
questionnaire responses provided by over 270 health professionals and interest groups. They report 
a lack of clear care pathways from family physician or other primary care service to secondary 
services, a lack of secondary, multi-disciplinary services, and potentially high costs to patients.  
 
Attitudes that held patients responsible for their condition and their lack of commitment to 
treatment were also a concern, insofar as stigma experienced by patients can contribute to lack of 
treatment. Defining obesity as a disease may help to overcome stigma and improve patient referral 
and treatment adherence14, 15 and may also help to secure better funding streams for treatment 
services, and for prevention services which are a necessary adjunct to reduce the risk of weight 
regain after treatment.16 However, many countries do not yet appear ready to recognise obesity as a 
disease, especially in lower income countries. Rapid changes will be needed in health systems 
worldwide in order to provide treatment for people living with obesity commensurate with the 
United Nations’ goal of Universal Health Coverage. 
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Table 1: Background data and number of interviews conducted in 68 countries 
 
  Predicted 
percentage of 
adults with BMI 
>=34.9 kg/m2 in 
2025 (1) 
Predicted number 
of adults with BMI 









Low and lower-middle income  
1.  Bangladesh 0.7 7,861 2.37 1 
2.  Cameroon  4.6 682 4.69 5 
3.  Egypt 15.5 9,970 4.64 4 
4.  El Salvador 8.3 379 6.96 1 
5.  Ethiopia 0.9 613 3.97 4 
6.  India 0.9 8,246 3.66 12 
7.  Indonesia 1.5 2,875 3.12 3 
8.  Kenya 2.6 779 4.55 5 
9.  Morocco 7.6 1,956 5.84 1 
10.  Myanmar 1.1 439 5.09 1 
11.  Nicaragua  7.9 358 8.75 3 
12.  Nigeria 5.0 5,450 3.65 7 
13.  Pakistan 1.7 2,227 2.75 4 
14.  Philippines 1.5 1,099 4.39 4 
15.  Tanzania 2.4 807 4.14 1 
Upper-middle income  
16.  Albania 4.8 109 6.7 1 
17.  Argentina 12.3 4,083 7.55 7 
18.  Brazil 8.0 13,265 11.77 5 
19.  Bulgaria 6.6 351 8.23 3 
20.  China 1.5 16,030 4.98 1 
21.  Colombia 7.0 2,642 5.91 4 
22.  Ecuador 6.3 773 8.39 1 
23.  Fiji 12.6 76 3.46 1 
24.  Georgia 8.0 245 8.44 1 
25.  Guatemala 7.0 820 5.82 6 
26.  Iran 7.9 4,870 8.10 5 
27.  Iraq 9.4 2,263 3.31 5 
28.  Jordan 14.8 732 5.47 4 
29.  Lebanon 11.5 457 8.02 4 
30.  Malaysia 5.7 1,380 3.80 5 
31.  Mauritius 7.6 78 5.75 1 
32.  Mexico 12.6 12,235 5.47 20 
33.  Paraguay 7.2 343 8.02 3 
34.  Peru  6.4 1,511 5.14 4 
35.  South Africa 15.1 5,703 8.11 1 
36.  Sri Lanka 2.0 323 3.89 3 
37.  St Lucia 13.0 19 5.31 1 
38.  Thailand 3.1 1,720 3.71 3 
High income  
39.  Australia 13.4 2,705 9.25 7 
40.  Austria  6.9 489 10.44 2 
41.  Barbados 14.4 33 6.96 4 
42.  Belgium 6.4 590 10.04 2 
43.  Canada  13.0 3,993 10.53 4 
44.  Chile 12.5 1,879 8.53 8 
45.  Germany  7.3 4,827 11.14 3 
46.  Greece 8.8 777 8.45 4 
47.  Hong Kong  1.6 100 6.2 7 
48.  Ireland 11.4 427 7.38 7 
49.  Israel 9.0 556 7.31 4 
50.  Italy 7.1 3,495 8.94 4 
51.  Kuwait 17.1 539 3.90 6 
52.  Netherlands 5.9 810 10.36 7 
53.  New Zealand 15.1 558 9.22 2 
54.  Norway 9.5 415 10.50 1 
55.  Oman 11.4 354 4.29 5 
56.  Portugal 6.2 525 9.08 1 
57.  Qatar 19.4 369 3.08 2 
58.  Saudi Arabia  16.1 3,763 5.74 6 
59.  Singapore 1.2 60 4.47 2 
60.  South Korea 0.6 276 7.34 3 
61.  Spain 8.6 3,269 8.97 3 
62.  Sweden 7.0 555 10.93 3 
63.  Switzerland 6.6 471 12.25 3 
64.  Taiwan 1.5 287 6.14 3 
65.  UAE 15.0 1,079 3.52 8 
66.  UK England 12.8 5,990 9.8 7  67.  UK Scotland 525 3 
68.  USA 20.1 52,381 17.07 8 
 274 
  
(1) World Obesity Federation estimates 5  
 
(2) World Bank 2019: https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS plus Hong Kong: 




Table 2: Self-declared status of respondents 
 








Number of countries 68 15 23 30 22 22 22 22 
Physician / clinician / 
internal medicine 
37 9 10 18 14 16 12 15 
GP / family physician 28 4 5 9 9 16 10 8 
Bariatric surgeon 27 5 9 13 6 10 8 5 
Endocrinologist 26 4 9 13 7 8 8 8 
Paediatrician  10 1 2 7 3 4 3 6 
Nurse 4 2 1 12 2 2 2 2 
Nutritionist / dietitian 59 10 34 15 15 29 19 9 
Physical activity specialist 7 4 2 1 5 2 6 1 
Psychologist, or health 
promotion specialist 
13 2 3 8 4 6 3 6 
Pharmacist 4 1 1 2 2 1 1 1 
Advocacy or civil 
organisation staff member 
8 3 0 5 4 4 4 4 
Patient 10 1 2 7 1 7 2 5 
Researcher / student / 
unspecified 
40 10 11 19 11 15 13 14 
Total 274 56 89 129 83 120 91 84 
 
LLMI: Low and lower-middle income countries; UMI: Upper-middle income countries; HI: High income countries. 
Low HCE: lowest tertile for health care expenditure; High HCE: highest tertile for health care expenditure. 
Lower prevalence: lowest tertile for prevalence of severe obesity; Higher prevalence: highest tertile for prevalence of 
severe obesity. 
  
Table 3: Number of countries claiming ‘yes’ for specified obesity care issues 
Data shown are number of countries in which a consensus of respondents stated ‘YES’.  
 
  










Total number of countries 68 15 23 30 22 23 22 23 
Professional guidelines for treatment 42 6 15 21 13 17 14 12 
   X2=3.99, p=0.14 X2=1.11, p=0.29 X2=0.61, p=0.44 
Adequate training for … 
 Nutritionist/dietitian 29 5 12 12 10 8 10 10 
 GP/family physician 17 2 7 8 7 3 7 6 
 Bariatric surgeon 16 1 4 11 3 5 5 7 
 Endocrinologist 11 2 5 4 3 2 3 2 
 Nurse 11 0 5 6 2 5 1 6 
 
Physical activity 
specialist 11 2 4 5 3 3 6 4 
 Psychologist 8 1 3 4 1 4 3 2 
 Internal medicine 7 0 3 4 1 2 2 1 
 Paediatrics 4 0 1 3 0 3 1 1 
   w=0.72, p<0.05 r=0.35, ns r=0.66, p<0.05 
Access to care services via … 
 GP / Primary care 36 4 11 21 11 14 8 17 
   X2=7.90, p<0.02 X2=0.54, p=0.46 X2=6.42, p<0.02 
 Following complications 30 10 8 12 10 9 10 10 
   X2=4.11, p=0.13 X2=0.18, p=0.67 X2=0.02, p=0.89 
 Specialists / hospital 10 1 4 5 3 3 3 4 
 Screening  7 0 1 6 3 3 2 4 
Reasons for leaving services … 
 No referral offered 32 6 10 16 11 11 12 14 
 Lack of care pathway 26 7 10 9 9 7 9 9 
 Treatment failure 19 2 6 11 4 8 4 8 
 
Lack of motivation or 
poor compliance 17 2 4 11 3 6 3 5 
 Cost 11 1 4 6 1 5 0 6 
 Lost to follow up 11 1 3 7 3 4 4 4 
 Long waiting list  7 0 3 4 0 2 0 4 
 
Stigma or perceived 
exclusion 5 1 3 1 2 1 2 2 
 Distance from home 2 0 1 1 0 0 0 1 
LLMI: Low and lower-middle income countries; UMI: Upper-middle income countries; HI: High income countries. 
Low HCE: lowest tertile for health care expenditure; High HCE: highest tertile for health care expenditure. 
Lower prevalence: lowest tertile for prevalence of severe obesity; Higher prevalence: highest tertile for prevalence of 
severe obesity.  
X2 is Chi squared, w is Kendall’s coefficient of concordance, r is Spearman’s rank correlation coefficient  
Table 4: Ratings on obesity care services  
Mean rating value (number of countries giving a consensus response) 
(0 = ‘no’ or ‘poor’; 10 = ‘yes’ or ‘excellent’) 
















4.2 (67)  3.3  
(15) 








  X2=3.52, p=0.17 X2=6.36, p=0.01 X2=0.61, p=0.44 
Availability 
of services in 
urban areas 
4.5 (65) 3.5 
(14) 








  X2=3.27, p=0.19 X2=0.02, p=0.88 X2=6.29, p=0.01 
Availability 
of services in 
rural areas 
2.3 (59) 1.2  
(13) 
2.2 (23) 3.1 (23) 1.8  
(18) 




  X2=2.33, p=0.31 X2=1.80, p=0.17 X2=3.59, p=0.06 
Comparison 
























5.0 (68) 3.8  
(15) 
5.4 (23)  5.2 (30)  5.0  
(22) 












4.9 (68) 4.1 
(15) 
4.8 (23)  5.3 (30)  5.0  
(22) 




  X2=5.66, p=0.06 X2=0.69, p=0.41 X2=0.03, p=0.85 
Data shown are unweighted means of each county’s average rating.  
X2 is Chi squared.   
LLMI: Low and lower-middle income countries; UMI: Upper-middle income countries; HI: High income countries. 
Low HCE: lowest tertile for health care expenditure; High HCE: highest tertile for health care expenditure. 
Lower prevalence: lowest tertile for prevalence of severe obesity; Higher prevalence: highest tertile for prevalence of 
severe obesity.  
X2 is Chi squared 
  
Table 5: Perceived barriers to treatment 
Sum of ‘top five’ responses 
 
 All rank LLMI rank UMI rank HI rank 
Lack of political will and interest  7.5 1 2.4 1 2.9 1 2.2 5 
Lack of training for HCP's and lack of trained HCP's 6.1 2 1.3 3 1.8 4 3.1 1 
High cost of out of pocket payments  5.6 3 1.3 4 1.9 3 2.5 3 
Poor health literacy and behaviour 5.2 4 1.5 2 1.3 7 2.4 4 
Obesity not recognised as a disease 4.7 5 1.3 5 1.3 6 2.2 6 
Lack of investment in health system; lack of funding 
for coverage 4.7 6 0.8 6 2.1 2 1.7 7 
Stigma, blame and belief in individual responsibility 3.2 7 0.0 30 0.6 15 2.7 2 
Food costs; obesogenic food environments 3.1 8 0.6 8 1.7 5 0.8 13 
Cultural norms and traditions around obesity 2.5 9 0.6 7 0.8 10 1.1 9 
Lack of evidence, monitoring and research 2.3 10 0.3 12 1.3 8 0.7 15 
Poor availability of pharmaceutical treatments 1.8 11 0.2 22 0.8 9 0.9 11 
Food industry influence on environment and narrative 1.8 12 0.5 9 0.6 13 0.7 14 
Lack of treatment facilities; long waiting lists 1.7 13 0.1 26 0.5 17 1.1 8 
Failure to recognise treatment options; excess focus on 
surgery 1.6 14 0.1 24 0.4 21 1.1 10 
Poor adherence to treatment; fear of treatment 1.5 15 0.2 15 0.7 12 0.6 17 
Fragmented or failing health system 1.5 16 0.4 10 0.5 16 0.5 20 
Lack of opportunity for physical activity or safe active 
transport 1.3 17 0.2 17 0.5 18 0.6 18 
Obesogenic environment (not specified) 1.3 18 0.2 19 0.5 19 0.6 16 
Lack of multi-disciplinary teams 1.1 19 0.0 29 0.6 14 0.5 19 
Social determinants of health; social deprivation 1.1 20 0.3 14 0.4 20 0.4 22 
Lack of time with GP; lack of assessment and referral 1.0 21 0.2 20 0.0 29 0.8 12 
Obesity a sign of wealth and status 0.9 22 0.2 21 0.7 11 0.0 30 
Lack of treatment guidelines or pathway; failure to 
follow guidelines 0.9 23 0.2 16 0.2 24 0.5 21 
Health care professional disinterest in obesity training 
or treatments 0.8 24 0.3 11 0.1 26 0.3 24 
Patients’ lack of knowledge of available treatment 
options 0.7 25 0.1 25 0.2 23 0.4 23 
Lack of patient support groups or national associations 0.6 26 0.3 13 0.1 25 0.2 27 
Economic crisis affecting services 0.6 27 0.0 28 0.3 22 0.3 25 
New technology not supported or reimbursed 0.4 28 0.2 18 0.1 27 0.1 28 
Use of inappropriate 'treatments' 0.3 29 0.0 27 0.1 28 0.2 26 
Unrealistic expectations of treatment 0.2 30 0.2 23 0.0 30 0.1 29 
   w=0.73, p<0.001 
 
LLMI: Low and lower-middle income countries; UMI: Upper-middle income countries; HI: High income countries 
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Supplementary table 1: Low and high tertile countries 
 







BMI >34.9 kg/m2  
Higher projected 
prevalence of BMI 
>34.9 kg/m2 
Bangladesh Australia Albania Argentina 
Cameroon  Austria  Bangladesh Australia 
China Belgium Cameroon  Barbados 
Egypt Brazil China Canada  
Ethiopia Bulgaria Ethiopia Chile 
Fiji Canada  Hong Kong  Egypt 
India Chile India Fiji 
Indonesia Ecuador Indonesia Ireland 
Iraq Georgia Kenya Jordan 
Kenya Germany  Malaysia Kuwait 
Kuwait Greece Myanmar Lebanon 
Malaysia Italy Netherlands Mexico 
Nigeria Netherlands Nigeria New Zealand 
Oman New Zealand Pakistan Norway 
Pakistan Nicaragua  Philippines Oman 
Philippines Norway Portugal Qatar 
Qatar Portugal Singapore Saudi Arabia  
Singapore Spain South Korea South Africa 
Sri Lanka Sweden Sri Lanka St Lucia 
Tanzania Switzerland Taiwan UAE 
Thailand UK Tanzania UK 






Supplementary material: Interview protocol 
 
Note:  Questions in bold are key questions that all interviewees should be asked. Other questions are ‘nice to have’  
 
Obesity as a Disease 
"Please rate between 0 - 10 where your country's GOVERNMENT is in the journey towards defining ‘Obesity as a 
disease’ (0 = not considered a disease, 10 = Obesity defined as a disease).  Please explain your rating. 
 
"Please rate between 0 - 10 where your country's HEALTHCARE PROVIDER is in the journey towards defining 
‘Obesity as a disease’  (0 = not considered a disease, 10 = Obesity defined as a disease).  Please explain your rating. 
 
"Where is your country in recognising obesity as a disease in respect to medical societies?   
"Is Obesity described as a disability in terms of employment?   If yes, is comprehensive or on an ad hoc basis? 
 
Finance 
What obesity interventions are covered by government funding and/or social insurance (if any)? 
"How is obesity treatment generally funded in practice? Government funding, insurance or out of pocket?  Please 
consider the case for all interventions. 
 




"Please outline what your country is doing to PREVENT obesity?   
 
Please rate between 0 - 10 how your health system is working in terms of obesity prevention and treatment (0 = 
not working at all, 10 = working well).  Please explain your rating. 
 
"How could obesity be better prevented in your country? (Up to 3 suggestions) 
 
Obesity Treatment  
"At what threshold of obesity do individuals become ELIGIBLE for obesity treatment? E.g. BMI ≥30, ≥ 35 or ≥ 40 
kg/m² (with or without related co-morbidities)." 
 
"In reality, do individuals actually receive treatment when they should? If not, why not and at what level of BMI do 
they receive treatment? E.g. BMI ≥30, ≥ 35 or ≥ 40 kg/m² (with or without related co-morbidities). " 
 
"How do people with obesity usually enter the health system & who doesn't enter the system?   
"How do people with obesity usually leave/fall out of the health system?   
 
What do you consider to be the Top 5 barriers to obesity treatment in your country? 
 
Describe the typical clinical pathway. How is someone treated in primary, secondary and tertiary care? 
 
Primary Care Strategy  
Is it routine to take height and weight measurements in consultation and do they record BMI?   Is the information 




"Is a discussion held if they are found to be at an unhealthy BMI?  If a discussion is not held, what reasons are given 
for not holding a conversation?  
 
NCD National Strategies 
Does your country have a national strategy on NCDs?  Does it have an implementation guide?   
 
Does the national strategy include obesity?  If so, how does it include it?  Is there anything related to obesity that is 
working particularly well or poorly? Please explain and give examples. 
 
If your country does not have an NCD strategy, please give your views on why this is the case. 
 
Health Professionals 
"Please rate between 0 - 10 the availability of suitably qualified obesity treatment professionals in urban areas. (0 = 
not available, 10 = widely and easily available to all) If specific professions are in short supply please identify:" 
 
"Please rate between 0 - 10 the availability of suitably qualified obesity treatment professionals in rural areas. (0 = 
not available, 10 = widely and easily available to all) If specific professions are in short supply please identify:" 
 
Specialist Obesity Training  
Is specialist obesity training available across the Health System?  What professions are included?   
 
Is specialist obesity training up to date and appropriate?  Is it mandatory?  
 
If specialist obesity training is available, are trainees funded to train or are they required to self fund? 
 
Is there formal recognition available for obesity specialisation? 
 
If specialist obesity training is not available, please could you suggest why this may be the case. 
 
Are there any gaps/specific needs not currently addressed in the specialist training? 
 
Are you aware of any other specialist training available to healthcare professionals, perhaps online or abroad? If so, 
please could you specify? 
 
Recommendations/Guidelines 
Do any government bodies have any obesity-related treatment recommendations or guidelines for adults or 
children? Are they current?  Evidence-based? Please obtain details or a link.  
 
Do any non-government bodies have any obesity-related treatment recommendations or guidelines for adults or 
children? Are they current?  Evidence-based? Please obtain details or a link.  
 
If your country has guidelines, please rate the uptake amongst healthcare practitioners (0 = no uptake, 10 = complete 
uptake). Please explain your rating. 
 
Political Influences 





"What are the cultural considerations in terms of obesity?  
 
Patient Networks  
"Do your patients advocate in any way for themselves?   Are they visible or vocal? Do they have a network?   
 





Supplementary material: Online survey protocol 
 
 
We encourage responses from all professions – clinicians, researchers, students, policy-makers and 
more. No questions are mandatory to reflect this – just answer as much as you can! 
 
Please note that while we ask for your details, responses are pooled and presented anonymously.  
 
1Please complete your details 
Name:    
Professional Role:  
Email:    
Country:   
 
2Please rate between 0 - 10 where your country's GOVERNMENT is in the journey towards 
defining ‘Obesity as a disease’. 
 
(0 = not considered a disease, 10 = Obesity defined as a disease) 
0  10 
 
3Please take a few moments to explain your rating in Question 2 
 
 
4Please rate between 0 - 10 where your country's HEALTHCARE PROVIDER is in the journey 
towards defining ‘Obesity as a disease’. 
 
(0 = not considered a disease, 10 = Obesity defined as a disease) 
0  10 
 





6Please rate between 0 - 10 how your health system is working in terms of obesity prevention and 
treatment. 
 
(0 = not working at all, 10 = working well) 
0  10 
 
7Please take a few moments to explain your rating in Question 6 
 
 
8Please outline what your country is doing to PREVENT obesity?  For example, there may be 
school-led interventions, city-wide interventions or mandatory food labelling. 
 
 








11What obesity interventions are covered by government funding and/or social insurance (if any)? 






12How is obesity treatment generally funded in practice? Government funding, insurance or out 
of pocket? E.g. Individuals may pay out of pocket because of long waiting lists for public services.  
Please consider the case for all interventions. 
Lifestyle and behavioural  
8 
 
Pharmacological   
Surgical    
Other (please specify)   
 
13Please identify what your country is doing very well or very poorly in terms of financial support 
for obesity prevention/treatment/management? 
 
14Does your country have a National Strategy on NCDs (non-communicable diseases)?   
Yes 
No - Please go to Q17 
Unsure / Don't know 
 
15Does your country’s NCD strategy have an implementation guide? Please comment: 
 
 
16 Is there anything in the NCD strategy related to obesity that is working particularly well or 
poorly? Please provide details or examples here: 
 
 
17 If your country does not have an NCD strategy, please give your views on why this is the case  
(Skip this question if your country has an NCD strategy) 
 
 
Non-clinicians, please skip this page if unable to answer these questions.  
 









19To what extent does an individual have to suffer obesity to be ELIGIBLE for obesity 
treatment? E.g. BMI ≥30, ≥ 35 or ≥ 40 kg/m² (with or without related co-morbidities).       
Lifestyle and behavioural  
Pharmacological   
Surgical    
Other (please specify)   
 
20 In reality, do individuals actually receive treatment when they should? If not, why not and at 
what level of BMI do they receive treatment? E.g. BMI ≥30, ≥ 35 or ≥ 40 kg/m² (with or without 
related co-morbidities).  
Lifestyle and behavioural  
Pharmacological   
Surgical    
Other (please specify)   
 
21How do people with obesity usually enter the health system? Who doesn't enter the system?  
For example, those living in rural communities may have restricted access to facilities so never 
enter the health system. 
 
 




23How do people with obesity usually leave/fall out of the health system?  For example, they may 
not be referred for specialist obesity treatment or they may successfully lose weight.   
 
 
24Please rate between 0 - 10 the availability of suitably qualified obesity treatment professionals 




(0 = not available, 10 = widely and easily available to all) 
0  10 
 
25 If specific professions from Q24 are in short supply please identify below 
 
 
26Please rate between 0 - 10 the availability of suitably qualified obesity treatment professionals 
in rural areas. 
 
(0 = not available, 10 = widely and easily available to all) 
0  10 
 
27 If specific professions from Q26 are in short supply please identify below 
 
 
28Do any government bodies have any obesity-related treatment recommendations or guidelines 
for adults or children? Please provide details. 
Adults   
Children  
 
29Do any non-governmental bodies (e.g. networks, institutes, organisations) have any obesity-
related treatment recommendations or guidelines for adults or children? Please provide details 
Adults   
Children  
 
30 If your country has guidelines, please rate the uptake amongst healthcare practitioners?  
(0 = no uptake, 10 = complete uptake) 
11 
 
0  10 
 
31Please take a moment to explain your rating in Question 30. 
 
32What specialist obesity training is available across the health system? 
 
 
33 If specialist obesity training is available, is it nationally or regionally available? 
 
 
34 If specialist obesity training is available, what professions are included? 
 
 
35Does your country implement any particularly successful or innovative technologies for tackling 
obesity?  Equally, if you have any experience of any unsuccessful use of technologies please 
describe this below. 
 
 
36Who else should we interview to obtain a good picture of obesity management in your country? 
 
 
37Would you be happy to be contacted again about this project and other World Obesity 
Federation programmes? 
Yes 
No 
 
 
 
